2026 Safety Pharmacology Society Annual Meeting

HESI Global Committees will be presenting at the 2026 Safety Pharmacology Society Annual Meeting.

HESI Global Collaborative Effort to Revise ICH S7A
Title: Evolution of Regulatory Safety and Secondary Pharmacology: Time for a New Era: Reopening and revision of ICH S7A
Speaker: Jean-Pierre Valentin, UCB
Program link

Cardiac Safety
Title: Integrated Cardiovascular Strategies Working Group: Evaluation of Drug-Induced Effects on Blood Pressure in Rat and Canine PK/PD Models—Insights from the HESI Consortium
Speaker: Mike Foley, Abbvie
Program link

Title: Bridging the Last Mile: Bringing Cardiac NAMs to Practice
Speaker: Jennifer Pierson, HESI Associate Director
Program link

Targeted Protein Degrader Safety
Title: Targeted Protein Degrader / QTc Working Group: Improving Understanding of Mechanism and Translation —Insights from the HESI Consortium
Speakers: Brad Enerson, Kymera and Jill Steidl-Nichols, Amgen
Program link